Vilacto Bio Inc. (OTCMKTS:ZFLOD) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Vilacto Bio Inc. (OTCMKTS:ZFLOD) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Story continues below

ITEM 5.03 Amendments to Articles of Incorporation or Bylaws;
Change in Fiscal Year.

On March 6, 2017, our board of directors resolved to increase the
number of authorized shares of our common stock, par value
$0.001, from 75,000,000 shares to 1,125,000,000 shares.
Correspondingly, our board of directors affirmed a forward split
of 15 for 1 in which each shareholder will be issued 15 common
shares in exchange for 1 common share of their currently issued
common stock. Under the Nevada law, shareholder approval was not
required.

Prior to approval of the forward split, we had a total of
6,000,000 issued and outstanding common shares, par value $0.001.
On the effective date of the forward split, we will have a total
of 90,000,000 issued and outstanding common shares, par value
$0.001. New stock certificates will be issued upon surrender of
the shareholders old certificates.

On March 13, 2017, we filed Articles of Merger with the Secretary
of State of Nevada in order to effectuate a merger with our
wholly-owned subsidiary, Vilacto Bio Inc. Shareholder approval
was not required under Section 92A.180 of the Nevada Revised
Statutes. As part of the merger, our board of directors
authorized a change in our name to Vilacto Bio Inc. and our
Articles of Incorporation have been amended to reflect this name
change.

A copy of the Articles of Merger is attached to this Current
Report as Exhibit 3.1 and is incorporated by reference herein.

In connection with the forward split and name change, we have the
following new CUSIP number: 92686M 109. We have submitted the
required information to FINRA and we have been provided an
effective date of April 4, 2017. Once effective, our common stock
will be quoted under the symbol ZFLOD for a period of 20 trading
days. After 20 trading days, our common stock will trade under
the symbol VIBI that more resembles our new name.

SECTION 9 Financial Statements and Exhibits

ITEM 9.01 Financial Statements and Exhibits

Exhibit No. Description
3.1 Certificate of Merger, dated March 13, 2017


About Vilacto Bio Inc. (OTCMKTS:ZFLOD)

Vilacto Bio Inc., formerly Zlato Inc., is engaged in the development and sale of electronic medical record (EMR) software for small and medium sized physician offices and clinics. Its basic EMR software collects and captures patient data electronically, and stores it in a format that enables access, viewing and distribution by printing or e-mail. Its planned second phase product development will focus on interconnectivity of its EMR software with various third-party vital signs monitors, such as blood pressure monitors or temperature monitors. Its basic EMR software has been developed to provide online, real time computer access, and contains a physician/medical personnel interface and an electronic database backend, which collects and organizes all patient data. Its EMR database is backed up instantly when data is entered. The backup facilities can either be managed in house on separate servers or with independent third-party data storage facilities.

Vilacto Bio Inc. (OTCMKTS:ZFLOD) Recent Trading Information

Vilacto Bio Inc. (OTCMKTS:ZFLOD) closed its last trading session at 0.0000 with shares trading hands.

An ad to help with our costs